HomeCompareUCBJY vs VICI

UCBJY vs VICI: Dividend Comparison 2026

UCBJY yields 0.52% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $968.1K in total portfolio value
10 years
UCBJY
UCBJY
● Live price
0.52%
Share price
$150.79
Annual div
$0.79
5Y div CAGR
7.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.7K
Annual income
$111.23
Full UCBJY calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — UCBJY vs VICI

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUCBJYVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UCBJY + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UCBJY pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UCBJY
Annual income on $10K today (after 15% tax)
$44.56/yr
After 10yr DRIP, annual income (after tax)
$94.55/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, VICI beats the other by $529,677.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UCBJY + VICI for your $10,000?

UCBJY: 50%VICI: 50%
100% VICI50/50100% UCBJY
Portfolio after 10yr
$504.8K
Annual income
$311,686.27/yr
Blended yield
61.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

UCBJY
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
6.1
Piotroski
8/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UCBJY buys
0
VICI buys
0
No recent congressional trades found for UCBJY or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUCBJYVICI
Forward yield0.52%6.57%
Annual dividend / share$0.79$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR7.3%44.3%
Portfolio after 10y$20.7K$988.8K
Annual income after 10y$111.23$623,261.32
Total dividends collected$810.00$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: UCBJY vs VICI ($10,000, DRIP)

YearUCBJY PortfolioUCBJY Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$10,756$56.25$11,368$948.43$612.00VICI
2$11,570$60.67$13,339$1,493.16$1.8KVICI
3$12,445$65.44$16,326$2,426.21$3.9KVICI
4$13,387$70.59$21,123$4,112.15$7.7KVICI
5$14,400$76.15$29,379$7,368.23$15.0KVICI
6$15,490$82.14$44,804$14,191.64$29.3KVICI
7$16,663$88.60$76,658$29,972.12$60.0KVICI
8$17,925$95.58$150,894$71,015.81$133.0KVICI
9$19,283$103.11$350,814$193,582.47$331.5KVICI
10$20,744$111.23$988,809$623,261.32$968.1KVICI

UCBJY vs VICI: Complete Analysis 2026

UCBJYStock

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, Italy, the United Kingdom, Ireland, China, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Full UCBJY Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this UCBJY vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UCBJY vs SCHDUCBJY vs JEPIUCBJY vs OUCBJY vs KOUCBJY vs MAINUCBJY vs NNNUCBJY vs EPRTUCBJY vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.